Astera Labs, Inc.
ALAB
$287.48
$43.2217.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 104.18% | 115.13% | 136.51% | 163.80% | 200.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 104.18% | 115.13% | 136.51% | 163.80% | 200.19% |
| Cost of Revenue | 102.26% | 121.46% | 159.83% | 184.84% | 218.73% |
| Gross Profit | 104.79% | 113.17% | 129.79% | 157.63% | 194.70% |
| SG&A Expenses | -5.31% | -22.99% | -4.77% | 22.72% | 68.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.76% | 32.54% | 49.29% | 70.77% | 99.39% |
| Operating Income | 1,126.73% | 249.42% | 199.46% | 142.19% | 76.68% |
| Income Before Tax | 1,225.91% | 366.76% | 283.33% | 201.24% | 123.66% |
| Income Tax Expenses | 110.57% | -159.71% | -506.93% | -385.03% | -233.44% |
| Earnings from Continuing Operations | 546.55% | 362.68% | 311.99% | 212.11% | 140.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 546.55% | 362.68% | 311.99% | 212.11% | 140.66% |
| EBIT | 1,126.73% | 249.42% | 199.46% | 142.19% | 76.68% |
| EBITDA | 1,385.94% | 259.64% | 206.79% | 147.64% | 80.16% |
| EPS Basic | 529.30% | 176.73% | 180.41% | 139.88% | 112.44% |
| Normalized Basic EPS | 1,211.66% | 184.60% | 168.00% | 138.41% | 107.18% |
| EPS Diluted | 583.70% | 170.42% | 173.79% | 136.31% | 110.67% |
| Normalized Diluted EPS | 1,333.44% | 178.28% | 162.83% | 135.48% | 106.14% |
| Average Basic Shares Outstanding | 5.98% | 26.91% | 62.68% | 127.36% | 284.43% |
| Average Diluted Shares Outstanding | 7.99% | 32.45% | 77.18% | 143.30% | 304.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |